Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice

Dalong Ni1, Dawei Jiang1,2, Christopher J Kutyreff1

  • 1Departments of Radiology and Medical Physics, University of Wisconsin, Madison, WI, 53705, USA.

Nature Communications
|December 22, 2018
PubMed

Insights

Novel molybdenum-based nanoclusters act as potent nano-antioxidants, effectively protecting against acute kidney injury (AKI) by scavenging reactive oxygen species (ROS) in preclinical models.

Area of Science:

  • Nanotechnology
  • Renal Medicine
  • Biochemistry

Background:

  • Acute kidney injury (AKI) is a significant cause of mortality, often linked to oxidative stress from reactive oxygen species (ROS).
  • Current AKI treatments are primarily supportive, highlighting the need for novel therapeutic agents that target ROS accumulation in the kidneys.

Purpose of the Study:

  • To develop and evaluate molybdenum-based polyoxometalate (POM) nanoclusters as targeted nano-antioxidants for the prevention and treatment of AKI.
  • To investigate the ROS-scavenging capabilities and renal accumulation of these novel POM nanoclusters.

Main Methods:

  • Synthesis of molybdenum-based polyoxometalate (POM) nanoclusters with inherent ROS-scavenging properties.
  • Evaluation of renal uptake and biodistribution using dynamic positron emission tomography (PET) imaging with 68Ga-EDTA.
  • Assessment of therapeutic efficacy in a mouse model of AKI through serum analysis, kidney tissue staining, and biomarker detection.

Main Results:

  • POM nanoclusters demonstrated preferential accumulation in the kidneys.
  • The nanoclusters effectively scavenged detrimental reactive oxygen species (ROS).
  • Significant alleviation of AKI symptoms was observed in mice treated with POM nanoclusters, confirmed by various physiological and histological assessments.

Conclusions:

  • Molybdenum-based POM nanoclusters show promise as effective nano-antioxidants for kidney protection against AKI.
  • These findings support further investigation into POM nanoclusters for treating AKI and other ROS-related diseases in clinical settings.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
701
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
445
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
353
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
927
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
332